Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
480
datasets available to search
ShareScore release 0.7.1
Dataset results
480 results for “Hormone Receptors”
Hydroxychloroquine, Abemaciclib and Endocrine Therapy in Hormone Receptor Positive (HR+)/Her 2 Negative Breast Cancer
ClinicalTrials.gov study NCT04316169. IPD Sharing: NO. Countries: 1. Publications: 0.
Hormone Receptor Positive Metastatic Breast Cancer (HR+ mBC) BIIB021 Plus Aromasin Schedule Finding
ClinicalTrials.gov study NCT01004081. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Phase 1b/2 Study of TTI-101 in Combination for Patients With Metastatic Hormone Receptor-Positive and HER2-Negative Breast Cancer
ClinicalTrials.gov study NCT05384119. IPD Sharing: NO. Countries: 1. Publications: 0.
A Vaccine (STEMVAC) With Standard Endocrine-Based Therapy or Chemotherapy for the Treatment of Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer
ClinicalTrials.gov study NCT07112053. IPD Sharing: NO. Countries: 1. Publications: 0.
Palbociclib Plus Fulvestrant in Women With Hormone Receptor Positive and Human Epidermal Growth Factor Receptor Type 2 Negative Locally Advanced or Metastatic Breast Cancer Previously Treated With a C
ClinicalTrials.gov study NCT04318223. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase II Study of HLX22 in Combination With Trastuzumab Deruxtecan in HER2-low, Hormone Receptor Positive Locally Advanced or Metastatic Breast Cancer Patients
ClinicalTrials.gov study NCT06832202. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neoadjuvant Response-guided Treatment of Slowly Proliferating Hormone Receptor Positive Tumors
ClinicalTrials.gov study NCT02592083. IPD Sharing: NO. Countries: 1. Publications: 0.
Danish Observational Study of Everolimus Plus Exemestane in Hormone Receptor (HR) Positive, Human Epidermal Growth Factor 2 (HER2) - Metastatic Breast Cancer
ClinicalTrials.gov study NCT02023359. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Role of Individualized Intervention(s) in Hormone-Receptor Positive Early-stage Breast Cancer
ClinicalTrials.gov study NCT03407768. IPD Sharing: NO. Countries: 1. Publications: 0.
LINE: Treatment Patterns in postmenopausaL Women With Hormone Receptor Positive Breast Cancer
ClinicalTrials.gov study NCT01561443. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Vaccine Therapy in Treating Patients With Stage IV Hormone Receptor Positive Breast Cancer
ClinicalTrials.gov study NCT01729884. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast Cancer
ClinicalTrials.gov study NCT06518837. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase 1b Study of TAK-700 in Postmenopausal Women With Hormone-receptor Positive Metastatic Breast Cancer
ClinicalTrials.gov study NCT01808040. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Open Study of Metronomic Oral Vinorelbine in Combination With Aromatase Inhibitors for the Treatment of Postmenopausal Women With Hormone Receptor Positive,HER2-negative, Advanced Breast Cancer Who
ClinicalTrials.gov study NCT02730091. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase III Study of Bevacizumab and Paclitaxel in Combination with Atezolizumab As a Treatment for Locally Advanced Unresectable or Metastatic Hormone Receptor-positive HER2 Negative Breast Cancer
ClinicalTrials.gov study NCT04732598. IPD Sharing: NO. Countries: 1. Publications: 0.
Prolonged Overnight Fasting and/or Exercise on Fatigue and Other Patient Reported Outcomes in Women With Hormone Receptor Positive Advanced Breast Cancer
ClinicalTrials.gov study NCT06123988. IPD Sharing: NO. Countries: 1. Publications: 0.
Durvalumab (MEDI4736) and Tremelimumab in Hormone Receptor-positive, Hypermutated Metastatic Breast Cancer Identified by Whole Exome Sequencing
ClinicalTrials.gov study NCT03608865. IPD Sharing: NO. Countries: 1. Publications: 0.
Dalpiciclib Plus Fulvestrant With Pyrotinib in Hormone Receptor-positive, HER2-low Advanced Breast Cancer That Progressed on Previous CDK4/6i Plus AI Therapy
ClinicalTrials.gov study NCT05806671. IPD Sharing: NO. Countries: 1. Publications: 0.
Pembrolizumab and Paclitaxel in Hormone Receptor-positive, hyperMUTATted Metastatic Breast Cancer Identified by Whole exOme sequeNcing ('MUTATION2')
ClinicalTrials.gov study NCT04946227. IPD Sharing: NO. Countries: 1. Publications: 0.
Pembrolizumab in Combination With Paclitaxel in the Hormone Receptor-positive Metastatic Breast Cancer With High Tumor Mutational Burden Selected by Whole Exome Sequencing: Korean Cancer Study Group T
ClinicalTrials.gov study NCT03492918. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.